Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-15 18:51:49 EDT

PhotosVideosAllPeople
LatestRanked
Load more
@artherlessbyte8.bsky.socialOct 14, 2026, 11:25 PM

the flowers in all of their glory
#utdr #deltarune #undertale #tobyfox #jnj #jacknjellify #bfdi #bfdia #idfb #bfb #tpot #bfdie #battlefordreamisland

floweryorange and blueseth and aquayellow and green
S@stratiqai.appOct 14, 2026, 2:51 PM

StratIQ morning trading brief — Oct 14 🌅
Mixed start to the day.
Top driver: Johnson & Johnson bounce after a hard selloff: -5.7% Tue on a MedTech miss, even as it beat and….
Watching: $JNJ, $BX.
https://stratiqai.app/track-record?src=bluesky
Not financial advice.

@empiricalmarkets.bsky.socialOct 14, 2026, 10:30 AM

Key Mover for Oct 13: $JNJ (▼-5.73%)
Large-cap healthcare weakness was unusually sharp, with a 5.7% one-day decline.

@empiricalmarkets.bsky.socialOct 14, 2026, 10:15 AM

Anomalous Activity for Oct 13: $JNJ
$JNJ is one of the clearest divergent outliers today: Capital Flow +5.0σ, Relative Return -3.5σ, Relative Gap -2.8σ. Prior flow readings were muted, so this looks like a fresh burst of activity with weak relative price action.

@empiricalmarkets.bsky.socialOct 14, 2026, 10:15 AM

Anomaly Analysis for Oct 13:
Cross-sectional dispersion is elevated. Energy leaders $PSX, $VLO and $MPC pair strong Persistence with Relative Return strength, while $JNJ and $C show sharp Capital Flow surges alongside weak Relative Return. Semiconductor gaps remain a major downside cluster.

@tr3ndo.bsky.socialOct 13, 2026, 10:09 PM

#JNJ $JNJ

Anomalously high trading volume detected. False resistance breakout. False seller zone breakout. Buyer zone tested. Local minimum updated.

https://tr3n.do/stocks/jnj?utm_source=bluesky

JNJ daily technical analysis chart
@narrowit.bsky.socialOct 13, 2026, 4:10 PM

Johnson & Johnson Raises 2026 Sales Outlook After 5.9% Quarterly Growth Johnson & Johnson reported $25.4 billion of third-quarter sales and raised...

https://www.narrowit.com/news/johnson-johnson-q3-sales-guidance-talc-charge-2026-10-13
#JohnsonJohnson #JNJ #ThirdQuarter2026 #HealthCareEarnings

@premarketprice.bsky.socialOct 13, 2026, 2:30 PM

📉 $JNJ down -5.24% amid broad market rotation.
Trading at ~5.1× its typical daily move.
#JNJ #Healthcare

Full breakdown: https://premarketprice.com/analysis/JNJ?utm_source=bluesky&utm_medium=social&utm_campaign=movers

@stockmaster70.bsky.socialOct 13, 2026, 1:20 PM

📢 Stocks Trending NOW: #JPM #UNH #GS #JNJ #WFC #C #BMBL #CIFR #FRMI #PFAI

@tickertapenews.ioOct 13, 2026, 12:15 PM

$JNJ Q3 2026

Intäkter +5.9% YoY
EPS -95.8% YoY

• Innovative Medicine-omsättning +11,1% YoY
• Nettoresultat (GAAP) föll 95,9% till 210 miljoner dollar
• Rättsliga kostnader på 5,5 miljarder dollar påverkar resultatet

https://tickertapenews.io/artikel/?id=10485

@tr3ndo.bsky.socialOct 12, 2026, 9:45 PM

#JNJ $JNJ

Resistance tested. Seller zone tested. Buyer zone formed. Local minimum confirmed.

https://tr3n.do/stocks/jnj?utm_source=bluesky

JNJ daily technical analysis chart
@financiernews.bsky.socialOct 12, 2026, 4:34 PM

Closing Bell: Market Wrap

- JNJ trades at 263.02, up 0.60% on the session, as Wall Street braces for Q3 results after the closing bell.
- Analysts expect earnings of $2.53 a share, down 9.6%, on revenue of $25.38B, up 5.8%.

#JNJ #Earnings

https://financier.news/

Johnson & Johnson Jumps 0.60% to 263.02 as Wall Street Braces for Q3 Earnings With Profit Set to Fall 9.6%
@earningsforesight.bsky.socialOct 12, 2026, 4:12 PM

Earnings to Watch • Tuesday, October 13, 2026
#C #DPZ #GS #JNJ #JPM #UNH #WFC #AZZ

Photo, no description
@daysofourlives.bsky.socialOct 12, 2026, 10:58 AM

#OnThisDay in 1993, Matthew Ashford last appeared as Jack Deveraux, ending a 6 year run. He would return in 2001 #JnJ #ClassicDays #Days #DaysofourLives

Matthew Ashford ends his first run as Jack Deveraux on NBC soap opera Days of our Lives
@financiernews.bsky.socialOct 12, 2026, 1:57 AM

🩺 J&J Hits Record $157.44 as Traders Brace for October 13 Catalyst

Johnson & Johnson climbed 2.23% to $157.44, a 52-week high and its best level since October 2026, with the stock up 28.72% year to date.

#JNJ

https://financier.news/

Johnson & Johnson Stock Hits Record $157.44 as Traders Brace for October 13 Catalyst With 28.72% Year-to-Date…
@financiernews.bsky.socialOct 11, 2026, 2:12 PM

🩺 J&J Hits Record $157.44 as Traders Brace for October 13 Catalyst

Johnson & Johnson climbed 2.23% to $157.44, a 52-week high and its best level since October 2026, with the stock up 28.72% year to date.

#JNJ

https://financier.news/

Johnson & Johnson Stock Hits Record $157.44 as Traders Brace for October 13 Catalyst With 28.72% Year-to-Date…
@tickzen.bsky.socialOct 10, 2026, 7:47 PM

Scorecard updated for Johnson & Johnson Common Stock (JNJ). Score: 69/100 (Bullish Setup). Stance: Hold Existing Exposure. #JNJ

TickZen Stock scorecard chart
@tickzen.bsky.socialOct 10, 2026, 4:31 PM

Quick fair value update for $JNJ. Current price: $261.44 vs model estimate of $246.90. Rated as FAIRLY VALUED with -5.6 implied gap. #JNJ

TickZen Stock scorecard chart
@financiernews.bsky.socialOct 9, 2026, 4:11 PM

🩺 Icotyde Holds 72% Skin Clearance at Two Years in Psoriasis Trial

Johnson & Johnson said phase 3 ICONIC-LEAD data show at least 72% of plaque psoriasis patients on Icotyde (icotrokinra) kept high skin clearance past two years of treatment.

#JNJ

https://financier.news/

Johnson & Johnson Icotyde Keeps 72% Skin Clearance Beyond Two Years in Phase 3 Psoriasis Trial
@follow-the-money.usOct 7, 2026, 4:00 PM

Rep. Lloyd Doggett (D-TX) disclosed 1 trade:
Traded: Sep 8 | Disclosed: Oct 5

Bought: $JNJ ($1K-$15K)

https://integrityindex.us/candidate/lloyd-doggett